Showing results (1531-1540 of 1,713) with videos related to

Sort By:
Pageof 172
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding siteB M Baron, B L Harrison, I A McDonald, et al.
European Journal of Pharmacology|September 15, 1995
MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profilesJ H Kehne, B M Baron, B L Harrison, et al.
Iscience|December 13, 2021
Cryogenic electron microscopy reveals that applied pressure promotes short circuits in Li batteriesKatharine L Harrison, Laura C Merrill, Daniel Martin Long, et al.
JAMA Network Open|June 2, 2020
Effects of In-Person Navigation to Address Family Social Needs on Child Health Care Utilization: A Randomized Clinical TrialMatthew S Pantell, Danielle Hessler, Dayna Long, et al.
Journal of Cardiovascular Development and Disease|February 24, 2022
Optimising Cardiometabolic Risk Factors in Pregnancy: A Review of Risk Prediction Models Targeting Gestational Diabetes and Hypertensive DisordersEleanor P Thong, Drishti P Ghelani, Pamada Manoleehakul, et al.
Blood|November 9, 2000
Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemiaA Gajjar, P L Harrison, J T Sandlund, et al.
Journal of Pediatric Hematology/Oncology|December 29, 2000
Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El SalvadorM Bonilla, N Moreno, N Marina, et al.
Journal of the American Geriatrics Society|June 7, 2024
Geriatric conditions and healthcare utilization among older adults living in subsidized housingSarah E Kler, L Grisell Diaz-Ramirez, Kira L Ryskina, et al.
Leukemia|November 22, 1997
Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignanciesC H Pui, M V Relling, F Lascombes, et al.
The Biochemical Journal|November 2, 2002
Novel mesenchymal and haematopoietic cell isoforms of the SHP-2 docking receptor, PZR: identification, molecular cloning and effects on cell migrationAndrew C W Zannettino, Maria Roubelakis, Katie J Welldon, et al.
Pageof 172